Product Information
TEMOZOLOMIDE 140 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $11.4609 per EA under NDC 47335092974. Its NADAC has been published 152 times since Jul 21, 2021.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
140 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335092974
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201742On Market Since
2/13/2014
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 140 MG CAPSULE has been published 152 times since Jul 21, 2021, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4609 per EA |
|---|---|
| All-time high | $13.8362 (Jul 13, 2022) |
| All-time low | $6.5705 (Aug 21, 2024) |
| 52-week high | $11.4609 |
| 52-week low | $11.4609 |
| Median price | $11.4609 |
| Average price | $11.3901 |
| Largest weekly change | -38.7% (Aug 21, 2024) |
| Weeks tracked | 152 |
| Tracking since | Jul 21, 2021 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 140 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $11.4609 per EA (NDC 47335092974), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has declined 17.2%. It has been tracked across 152 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 140 MG CAPSULE?
Since Jul 21, 2021, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has ranged from a low of $6.5705 (Aug 21, 2024) to a high of $13.8362 (Jul 13, 2022), with a median of $11.4609 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 140 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 140 MG CAPSULE, is $10.7251 per EA — about 6% below TEMOZOLOMIDE 140 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 140 MG CAPSULE?
TEMOZOLOMIDE 140 MG CAPSULE (NDC 47335092974) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification